heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients undergoing elective midsternal cardiac surgery; 2. Age 18-65, both sexes; 3. ASA classification ?-?, NYHA classification ?-?; 4. Volunteer to join and sign informed consent after fully explaining the content of the clinical trial.
Exclusion criteria
Exclusion criteria: 1. The patient refused to participate; 2. Coagulopathy or infection at the puncture site; 3. Previous local anesthetic allergy; 4. Patients with chronic pain and long-term oral analgesics; 5. Complicated with serious diseases, such as abnormal liver and kidney function and lung function; 6. Poor control of diabetes and hypertension; 7. Patients undergoing emergency or secondary surgery; 8. People with severe mental illness or difficulty communicating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QOR-40 score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative pain scale;Opioid consumption;Time of first remedial analgesia;Inflammatory factor;Cardiac troponin I;Incidence of adverse reactions within 48 hours;Duration of mechanical ventilation;Incidence of pulmonary complications within 7 days after operation;ICU length of stay;Exhaust and defecation time;Postoperative activity time;Incidence of chronic pain; | — |
Countries
China